OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALLA56

Alliance Healthcare Group Ltd

Healthcare Facilities & ServicesVerified

Alliance Healthcare Group maintains a liquidity position with a current ratio of 1.18 and a debt-to-equity ratio of 0.73, indicating moderate leverage and a balanced capital structure. The company holds cash and equivalents of SGD 16,403,850, but its long-term debt of SGD 17,848,290 results in a net cash position that is negative after subtracting total debt. Profitability metrics show a return on equity of 6.25% and a return on assets of 1.67%, which are below the typical thresholds for high-performing healthcare service providers. These figures suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is distributed across six segments: GP clinic services, Specialist care services, Managed healthcare solutions, Pharmaceutical services, Mobile and digital health services, and Other. While the GP clinic and Specialist care services are core to its operations, the revenue concentration across these segments is not disclosed, making it difficult to assess the risk of overreliance on any single business line. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected for the next fiscal year. Historical revenue data does not indicate a strong growth trend, and the outlook remains neutral. Risk factors include moderate liquidity risk due to the current ratio being just above 1 and the negative net cash position. The company's dilution risk is assessed as low, with no immediate pressure from share issuance or dilution events. However, the presence of long-term debt and the absence of a clear capital structure strategy could pose challenges in the future. Recent filings and transcripts do not highlight any major events or strategic shifts. The company continues to operate within its core healthcare services, with no significant new product launches or market expansions disclosed in the latest financial reports.

30-day price · ALLA+0.01 (+3.3%)
Low$0.15High$0.16Close$0.15As of17 May, 00:00 UTC
Profile
CompanyAlliance Healthcare Group Ltd
TickerALLA.SI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Alliance Healthcare Group Limited provides primary and specialist healthcare services, managed healthcare solutions, pharmaceutical services, and mobile and digital health services in Singapore.

Classification. Alliance Healthcare Group is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Alliance Healthcare Group maintains a liquidity position with a current ratio of 1.18 and a debt-to-equity ratio of 0.73, indicating moderate leverage and a balanced capital structure. The company holds cash and equivalents of SGD 16,403,850, but its long-term debt of SGD 17,848,290 results in a net cash position that is negative after subtracting total debt. Profitability metrics show a return on equity of 6.25% and a return on assets of 1.67%, which are below the typical thresholds for high-performing healthcare service providers. These figures suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is distributed across six segments: GP clinic services, Specialist care services, Managed healthcare solutions, Pharmaceutical services, Mobile and digital health services, and Other. While the GP clinic and Specialist care services are core to its operations, the revenue concentration across these segments is not disclosed, making it difficult to assess the risk of overreliance on any single business line. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected for the next fiscal year. Historical revenue data does not indicate a strong growth trend, and the outlook remains neutral. Risk factors include moderate liquidity risk due to the current ratio being just above 1 and the negative net cash position. The company's dilution risk is assessed as low, with no immediate pressure from share issuance or dilution events. However, the presence of long-term debt and the absence of a clear capital structure strategy could pose challenges in the future. Recent filings and transcripts do not highlight any major events or strategic shifts. The company continues to operate within its core healthcare services, with no significant new product launches or market expansions disclosed in the latest financial reports.
Key takeaways
  • Alliance Healthcare Group maintains a moderate debt-to-equity ratio of 0.73, indicating a balanced capital structure.
  • The company's return on equity of 6.25% is modest and suggests limited profitability relative to its equity base.
  • Revenue is spread across multiple segments, but the lack of detailed concentration data raises questions about business diversification.
  • The company's liquidity position is stable, but its net cash is negative after subtracting total debt, signaling potential refinancing needs.
  • No significant growth or risk events are expected in the near term, with a neutral outlook for the next fiscal year.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySGD
Revenue$77.1M
Gross profit
Operating income$2.0M
Net income$1.5M
R&D
SG&A
D&A
SBC
Operating cash flow$5.7M
CapEx-$636.3k
Free cash flow$5.2M
Total assets$91.1M
Total liabilities$66.7M
Total equity$24.4M
Cash & equivalents$16.4M
Long-term debt$17.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$24.4M
Net cash-$1.4M
Current ratio1.2
Debt/Equity0.7
ROA1.7%
ROE6.2%
Cash conversion3.8%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
MetricALLAActivity
Op margin2.7%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin2.0%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin28.8% medp25 28.8% · p75 28.8%
CapEx / revenue-0.8%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity73.0%71.3% medp25 60.7% · p75 71.3%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 13:49 UTC#5fd77692
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 19:23 UTCJob: 5d02311a